Quince Therapeutics (QNCX) Stock Price, Quote, News & History | Benzinga

SPY777.29−0.16%QQQ743.86−0.99%BTC/USD82,651.44+1.12%DIA518.08+0.38%GLD382.24−0.61%TLT77.97−0.01%

Quince Therapeutics Inc (QNCX) Stock Price, Quote, News & History

QNCXNASDAQ

Trade with Public

Trade with Public

$31.73

N/A

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

-

Close

-

Volume / Avg.

- / 30.25K

Day Range

- - -

52 Wk Range

15.10 - 18.20K

Market Cap

$32.27M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

51

Short Interest

5.91%

Days to Cover

2.67

Recent Quince Therapeutics News

This Ares Management Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Analysts initiated coverage: ARES Overweight, $150; MGEE Neutral, $76; TTRX Buy, $24; QNCX Buy, $70; EFSC Buy, $70.

Avi Kapoor

Dow Jumps Over 1,300 Points; Delta Air Lines Shares Gain After Q1 Results

US stocks rose, Dow up 2.85%, Nasdaq up 3.33%, S&P 500 up 2.54%. Consumer discretionary shares up 3.9%, energy stocks down 6.6%.

Avi Kapoor

Why Levi Strauss Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket

Levi Strauss (LEVI) reported strong Q1 2026 results, raising revenue & earnings guidance. Other pre-market gainers include QNCX, VSME, UCAR, IPW, JEM, AZI, GPUS, AXTI, IPX.

Avi Kapoor

What Sparked Quince Therapeutics (QNCX) Stock To Rise 53% After Hours

Quince Therapeutics shares surged 53% after hours Thursday following the engagement of LifeSci Capital as financial advisor amid restructuring and strategic plans.

Mohd Haider

Quince Therapeutics Stock Plunges As Filing Shows Reverse Merger Plans, Bankruptcy Risks

Quince Therapeutics stock is trading sharply lower Thursday after the biotech company followed up Wednesday's rally with a Form 8-K that underscores how precarious its situation is.

Henry Khederian

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-46.92M

Investing Cash Flow (TTM)

26.29M

Financing Cash Flow (TTM)

121.79M

Free Cash Flow (TTM)

-47.00M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

101.15M

Analyst Trends and Forecast

2

Jun

1

Jul

1

Aug

1

Sep

1

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$83.45M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-659.09%

Earnings Yield % (FWD)

-10.91%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$34.73

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$115.98M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-